Leukemia Inhibitory Factor (LIF) Peptide
LIF
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN940098
Aperçu rapide pour Leukemia Inhibitory Factor (LIF) Peptide (ABIN940098)
Antigène
LIF
(Leukemia Inhibitory Factor (LIF))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- KVLAAGVVPL LLVLHWKHGA GSPLPITPVN ATCAIRHPCH NNLMNQIRSQ
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LIF antibody,
Alternative Names: LIF control peptide, LIF antibody Blocking Peptide, Anti-LIF Blocking Peptide, Leukemia Inhibitory Factor Blocking Peptide, Cholinergic Differentiation Factor Blocking Peptide, CDF Blocking Peptide, D-FACTOR Blocking Peptide, HILDA Blocking Peptide
-
-
Leukemia Inhibitory Factor (LIF) peptide (Ovalbumin)
LIF Reactivité: Porc Hôte: Synthetic WB, Imm, SDS
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- LIF (Leukemia Inhibitory Factor (LIF))
-
Sujet
- LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface.
-
Poids moléculaire
- 22 kDa
Antigène
-
Vous êtes ici:
